Patients' perspective of haemodialysis-associated symptoms.

UNLABELLED Introduction. Patients often report symptoms during haemodialysis (HD). To better understand patients' experience, we surveyed routine HD outpatients, to quantify the burden and duration of dialysis-associated symptoms. METHODS Five hundred and eight symptom questionnaires were returned from 550 HD outpatients (92.4%). The symptoms in relation to the HD session were analysed using a visual analogue score. Multivariate logistical regression analysis was used to identify characteristics associated with total symptom burden and time to recover following a HD session. RESULTS Fifty-four percent of the cohort were male, median age 64 years, 36% diabetic and median age unadjusted Charlson comorbidity score 3.0 (2-5). Fatigue (82%), intradialytic hypotension (76%), cramps (74%) and dizziness (63%) were the commonest symptoms reported, followed by headache (54%), pruritus (52%) and backache (51%), with fatigue occurring with a median frequency of 50% of dialysis sessions and intradialytic hypotension and cramps in 30%. Some 23% reported recovering from dialysis within minutes, 34% by the time they returned home, 16% by bed time, 24% the following morning and 3% just before the next dialysis session. Symptom burden was associated with female sex, younger age, longer duration of dialysis sessions, ethnicity and dialysis centre practice. The time taken to recover from dialysis varied from minutes to hours and was shorter for men and greater dialysis vintage but longer with increasing session time and those with increased intradialytic symptom burden. CONCLUSIONS Despite advances in HD, intradialytic symptoms were frequently reported by our patients. There was substantial unexplained variation in symptom burden across centres, suggesting that clinical practice or policies may play a role in preventing the adverse effects of dialysis. Symptom burden was worse in women, patients of South Asian as opposed to African origin and also in those receiving a longer duration of dialysis. These patients may therefore benefit from a different approach to dialysis prescription.

[1]  B. Freedman,et al.  An update on pruritus associated with CKD. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  A. Davenport,et al.  Is maximum conservative management an equivalent treatment option to dialysis for elderly patients with significant comorbid disease? , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[3]  A. Davenport Practical guidance for dialyzing a hemodialysis patient following acute brain injury , 2008, Hemodialysis international. International Symposium on Home Hemodialysis.

[4]  R. Lindsay DAILY HEMODIALYSIS—SELECTED TOPICS: The London, Ontario, Daily/Nocturnal Hemodialysis Study , 2004, Seminars in dialysis.

[5]  P. Kimmel,et al.  Cultural comparison of symptoms in patients on maintenance hemodialysis , 2008, Hemodialysis international. International Symposium on Home Hemodialysis.

[6]  A. Davenport Intradialytic complications during hemodialysis , 2006, Hemodialysis international. International Symposium on Home Hemodialysis.

[7]  A. Davenport Review article: Low‐molecular‐weight heparin as an alternative anticoagulant to unfractionated heparin for routine outpatient haemodialysis treatments , 2009, Nephrology.

[8]  A. Davenport Can Advances in Hemodialysis Machine Technology Prevent Intradialytic Hypotension? , 2009, Seminars in dialysis.

[9]  A. Davenport,et al.  Quality of life and emotional responses in cadaver and living related renal transplant recipients. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[10]  P. Bossuyt,et al.  Disturbed mineral metabolism is associated with muscle and skin complaints in a prospective cohort of dialysis patients. , 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  A. Davenport,et al.  Neuropsychological performance after kidney transplantation: a comparison between transplant types and in relation to dialysis and normative data. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[12]  Julia Addington-Hall,et al.  The prevalence of symptoms in end-stage renal disease: a systematic review. , 2007, Advances in chronic kidney disease.

[13]  G. Keusch,et al.  Reduced Complications during Hemodialysis by Automatic Blood Volume Controlled Ultrafiltration , 2007, The International journal of artificial organs.

[14]  A. Davenport,et al.  Cognitive functioning pre- to post-kidney transplantation--a prospective study. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  A. Figueiredo,et al.  Influence of sodium profile in preventing complications during hemodialysis , 2007, Hemodialysis international. International Symposium on Home Hemodialysis.

[16]  A. Davenport Membrane designs and composition for hemodialysis, hemofiltration and hemodialfiltration: past, present and future. , 2010, Minerva urologica e nefrologica = The Italian journal of urology and nephrology.

[17]  K. Digre,et al.  Expert Opinion , 1920, The Hospital.

[18]  C. Mackenzie,et al.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. , 1987, Journal of chronic diseases.

[19]  A. Davenport,et al.  Kt/V underestimates the hemodialysis dose in women and small men. , 2008, Kidney international.

[20]  Andrew Davenport,et al.  A wearable haemodialysis device for patients with end-stage renal failure: a pilot study , 2007, The Lancet.

[21]  D. Watson,et al.  Constructing validity: Basic issues in objective scale development , 1995 .

[22]  S. Weisbord,et al.  Undertreatment of symptoms in patients on maintenance hemodialysis. , 2010, Journal of pain and symptom management.

[23]  S. Fukuhara,et al.  Depressive symptoms predict the future risk of severe pruritus in haemodialysis patients: Japan Dialysis Outcomes and Practice Patterns Study , 2009, The British journal of dermatology.

[24]  A. Davenport,et al.  Acute neuropsychological changes in hemodialysis and peritoneal dialysis patients. , 2003, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[25]  Y. Berland,et al.  Tolerance of haemodialysis: a randomized cross-over trial of 5-h versus 4-h treatment time. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[26]  A. Davenport,et al.  The Importance of Dialysate Sodium Concentration in Determining Interdialytic Weight Gains in Chronic Hemodialysis Patients: The PanThames Renal Audit , 2008, The International journal of artificial organs.

[27]  A. Davenport,et al.  Illness and treatment cognitions and health related quality of life in end stage renal disease. , 2009, British journal of health psychology.

[28]  N. Gretz,et al.  Rat models of autosomal dominant polycystic kidney disease. , 1996, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[29]  S. Tepper,et al.  Headache and Hemodialysis: A Prospective Study , 2003, Headache.

[30]  I. Higginson,et al.  Symptoms in advanced renal disease: a cross-sectional survey of symptom prevalence in stage 5 chronic kidney disease managed without dialysis. , 2007, Journal of palliative medicine.

[31]  E. Weisshaar,et al.  How do nephrologists in haemodialysis units consider the symptom of itch? Results of a survey in Germany. , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  M. Bigal,et al.  Expert Opinion: Headaches and Hemodialysis , 2009, Headache.